Incorporating FLT3 Inhibitors into AML Treatment Regimens

$267,743P50FY2008CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Mark J Leviscontact

Linked publications & trials

Paper 39644068 Paper 39622255 Paper 39328363 Paper 39303729 Paper 39194286 Paper 39161899 Paper 39033444 Paper 38900051 Paper 38861934 Paper 38855634 Paper 38853641 Paper 38734670 Paper 38733986 Paper 38727135 Paper 38724550 Paper 38464203 Paper 38437498 Paper 38418901 Paper 38352538 Paper 38316746 Paper 38277619 Paper 38238616 Paper 38225226 Paper 38212207 Paper 38207208 Paper 38172923 Paper 38148395 Paper 38081370 Paper 38019903 Paper 37871574 Paper 37662296 Paper 37635400 Paper 37548050 Paper 37422688 Paper 37386016 Paper 37190037 Paper 37162954 Paper 37102976 Paper 37055414 Paper 36988276 Paper 36977823 Paper 36543374 Paper 36240061 Paper 36175679 Paper 36165535 Paper 36151141 Paper 35926182 Paper 35881110 Paper 35879429 Paper 35704787 Paper 35672446 Paper 35589701 Paper 35565416 Paper 35512203 Paper 35512188 Paper 35501304 Paper 35484100 Paper 35241842 Paper 35191020 Paper 35185150 Paper 35178503 Paper 35132195 Paper 35017466 Paper 34914826 Paper 34824242 Paper 34663807 Paper 34614211 Paper 34601571 Paper 34555853 Paper 34535769 Paper 34453686 Paper 34424319 Paper 34348451 Paper 34215503 Paper 34159633 Paper 34135465 Paper 34115096 Paper 34045454 Paper 34024982 Paper 34016956 Paper 33986022 Paper 33972549 Paper 33959279 Paper 33953290 Paper 33787984 Paper 33780038 Paper 33760042 Paper 33731681 Paper 33717142 Paper 33681815 Paper 33654205 Paper 33619261 Paper 33589747 Paper 33529373 Paper 33397444 Paper 33351114 Paper 33277313 Paper 33275752 Paper 33232480 Paper 33227136

View original record on NIH RePORTER →